Dolby Laboratories (DLB) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
DLB jumps 3.4% to $60.83, a 1-month high, 3 up days in a row. Closed at $60.83, +3.38% vs the prior close of $58.84. Day range $59.05–$60.88, opened at $59.05.
DLB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — DLB jumps 3.4% to $60.83, a 1-month high, 3 up days in a row
- Closed at $60.83, +3.38% vs the prior close of $58.84. Day range $59.05–$60.88, opened at $59.05.
- Volume was 479.70K shares, 0.5x its 50-day average of 893.70K — lighter than usual.
- Price is +0.2% vs its 50-day average ($60.72) and +2.4% vs its 200-day average ($59.38).
- 52-week range $48.26–$69.95; today's close sits at 58% of that range, 13.0% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 — DLB rises 0.8% to $58.84
- Closed at $58.84, +0.82% vs the prior close of $58.36. Day range $58.17–$59.07, opened at $58.41.
- Volume was 617.00K shares, 0.7x its 50-day average of 903.44K.
- Price is -3.1% vs its 50-day average ($60.73) and -1.0% vs its 200-day average ($59.41).
- 52-week range $48.26–$69.95; today's close sits at 49% of that range, 15.9% below the 52-week high.
Oct 13, 2026 — DLB rises 0.5% to $58.36
- Closed at $58.36, +0.50% vs the prior close of $58.07. Day range $58.14–$59.37, opened at $58.21.
- Volume was 504.10K shares, 0.5x its 50-day average of 922.33K — lighter than usual.
- Price is -4.0% vs its 50-day average ($60.78) and -1.8% vs its 200-day average ($59.44).
- 52-week range $48.26–$69.95; today's close sits at 47% of that range, 16.6% below the 52-week high.
Oct 12, 2026 — DLB dips 1.1% to $58.07
- Closed at $58.07, -1.14% vs the prior close of $58.74. Day range $57.70–$59.03, opened at $59.03.
- Volume was 551.00K shares, 0.6x its 50-day average of 947.18K — lighter than usual.
- Price is -4.5% vs its 50-day average ($60.81) and -2.4% vs its 200-day average ($59.48).
- 52-week range $48.26–$70.31; today's close sits at 44% of that range, 17.4% below the 52-week high.
Oct 9, 2026 — DLB rises 0.5% to $58.74
- Closed at $58.74, +0.50% vs the prior close of $58.45. Day range $58.47–$59.20, opened at $58.76.
- Volume was 583.90K shares, 0.6x its 50-day average of 958.50K.
- Price is -3.4% vs its 50-day average ($60.82) and -1.3% vs its 200-day average ($59.52).
- 52-week range $48.26–$71.24; today's close sits at 46% of that range, 17.5% below the 52-week high.
Oct 8, 2026 — DLB ends flat (+0.2%) to $58.45
- Closed at $58.45, +0.17% vs the prior close of $58.35. Day range $57.74–$59.07, opened at $58.16.
- Volume was 1.06M shares, 1.1x its 50-day average of 963.46K.
- Price is -3.7% vs its 50-day average ($60.68) and -1.9% vs its 200-day average ($59.56).
- 52-week range $48.26–$71.34; today's close sits at 44% of that range, 18.1% below the 52-week high.
Oct 7, 2026 — DLB ends flat (-0.2%) to $58.35
- Closed at $58.35, -0.19% vs the prior close of $58.46. Day range $57.53–$58.71, opened at $58.28.
- Volume was 691.00K shares, 0.7x its 50-day average of 966.62K.
- Price is -3.7% vs its 50-day average ($60.57) and -2.1% vs its 200-day average ($59.60).
- 52-week range $48.26–$72.96; today's close sits at 41% of that range, 20.0% below the 52-week high.
Oct 6, 2026 — DLB dips 1.5% to $58.46
- Closed at $58.46, -1.52% vs the prior close of $59.36. Day range $58.34–$59.68, opened at $59.68.
- Volume was 644.40K shares, 0.7x its 50-day average of 973.80K.
- Price is -3.3% vs its 50-day average ($60.45) and -2.0% vs its 200-day average ($59.64).
- 52-week range $48.26–$72.96; today's close sits at 41% of that range, 19.9% below the 52-week high.
Oct 5, 2026 — DLB rises 0.8% to $59.36
- Closed at $59.36, +0.80% vs the prior close of $58.89. Day range $58.19–$59.64, opened at $58.87.
- Volume was 758.60K shares, 0.8x its 50-day average of 972.97K.
- Price is -1.6% vs its 50-day average ($60.31) and -0.5% vs its 200-day average ($59.68).
- 52-week range $48.26–$72.96; today's close sits at 45% of that range, 18.6% below the 52-week high.
Oct 2, 2026 — DLB ends flat (-0.3%) to $58.89
- Closed at $58.89, -0.29% vs the prior close of $59.06. Day range $58.71–$59.45, opened at $59.45.
- Volume was 649.70K shares, 0.7x its 50-day average of 975.93K.
- Price is -2.0% vs its 50-day average ($60.12) and -1.4% vs its 200-day average ($59.72).
- 52-week range $48.26–$72.96; today's close sits at 43% of that range, 19.3% below the 52-week high.
Things to know before you trade DLB
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Jan 29, 2026, Nov 18, 2025. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.91% (largest 3.4%). That is a relatively calm stock.
- Liquidity: about 841.59K shares (≈$51.19M) trade per day on average.
- 52-week position: $60.83 vs a range of $48.26–$69.95 (58% of the range).
- Dividends: last ex-dividend date Aug 11, 2026 ($0.36/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: John D Couling sold 7,667 shares on Sep 1, 2026.
- Latest filings: 8-K Aug 27, 2026; 10-Q Jul 30, 2026; 8-K Jul 30, 2026.
- Listing: NYSE · industry: Patent Owners & Lessors.
DLB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 59.05 | 60.88 | 59.05 | 60.83 | 479.70K |
| Oct 14, 2026 | 58.41 | 59.07 | 58.17 | 58.84 | 617.00K |
| Oct 13, 2026 | 58.21 | 59.37 | 58.14 | 58.36 | 504.10K |
| Oct 12, 2026 | 59.03 | 59.03 | 57.70 | 58.07 | 551.00K |
| Oct 9, 2026 | 58.76 | 59.20 | 58.47 | 58.74 | 583.90K |
| Oct 8, 2026 | 58.16 | 59.07 | 57.74 | 58.45 | 1.06M |
| Oct 7, 2026 | 58.28 | 58.71 | 57.53 | 58.35 | 691.00K |
| Oct 6, 2026 | 59.68 | 59.68 | 58.34 | 58.46 | 644.40K |
| Oct 5, 2026 | 58.87 | 59.64 | 58.19 | 59.36 | 758.60K |
| Oct 2, 2026 | 59.45 | 59.45 | 58.71 | 58.89 | 649.70K |
| Oct 1, 2026 | 59.32 | 59.66 | 58.08 | 59.06 | 802.60K |
| Sep 30, 2026 | 58.25 | 59.18 | 58.08 | 58.77 | 602.50K |
| Sep 29, 2026 | 57.97 | 58.09 | 57.32 | 57.93 | 909.80K |
| Sep 28, 2026 | 58.07 | 58.47 | 57.65 | 58.19 | 669.80K |
| Sep 25, 2026 | 57.70 | 58.64 | 57.22 | 58.56 | 571.90K |
| Sep 24, 2026 | 58.01 | 58.98 | 56.39 | 57.56 | 837.60K |
| Sep 23, 2026 | 58.67 | 59.97 | 57.84 | 58.03 | 1.32M |
| Sep 22, 2026 | 58.11 | 58.57 | 56.49 | 58.40 | 1.63M |
| Sep 21, 2026 | 57.97 | 58.34 | 56.87 | 57.33 | 846.90K |
| Sep 18, 2026 | 57.54 | 57.85 | 57.07 | 57.65 | 2.11M |
About Dolby Laboratories
Dolby Laboratories (DLB) is listed on the NYSE and classified by the SEC under “Patent Owners & Lessors”. Its business address is in SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends September 27. SEC CIK 1308547.
DLB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David Dolby | Director | Feb 5, 2026 |
| Peter C Gotcher | Director | Feb 5, 2026 |
| Tony A Prophet | Director | Feb 5, 2026 |
| Emily Rollins | Director | Apr 3, 2026 |
| Simon Segars | Director | Feb 5, 2026 |
| Anjali Sud | Director | Feb 5, 2026 |
| Avadis Tevanian | Director | Feb 5, 2026 |
| Marc Whitten | President and CEO | Sep 17, 2026 |
| Kevin J Yeaman | President and CEO | Feb 9, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John D Couling | SVP, Entertainment | Sep 17, 2026 |
| Ryan Nicholson | VP, CAO and Corp. Controller | Aug 27, 2026 |
| Robert J Park | SVP & Chief Financial Officer | May 14, 2026 |
| Todd Pendleton | SVP, Chief Marketing Officer | May 27, 2026 |
| Shriram Revankar | SVP, Advanced Technology Group | Aug 18, 2026 |
| Mark Andrew Sherman | EVP, Gen. Counsel & Secretary | Sep 17, 2026 |
| Marc Whitten | President and CEO | Sep 17, 2026 |
| Kevin J Yeaman | President and CEO | Feb 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | John D Couling | Sale | 7,667 | $61.05 |
| Aug 25, 2026 | Ryan Nicholson | Sale | 1,183 | $65.28 |
| Aug 14, 2026 | Shriram Revankar | Sale | 3,000 | $62.71 |
| Aug 10, 2026 | Ryan Nicholson | Sale | 1,348 | $62.04 |
| Aug 4, 2026 | Ryan Nicholson | Sale | 357 | $60.63 |
| Aug 3, 2026 | John D Couling | Sale | 783 | $59.03 |
| Aug 3, 2026 | John D Couling | Sale | 6,884 | $60.11 |
| Jul 1, 2026 | John D Couling | Sale | 7,667 | $53.20 |
| Jun 1, 2026 | John D Couling | Sale | 7,158 | $55.59 |
| Jun 1, 2026 | John D Couling | Sale | 508 | $56.16 |
| May 22, 2026 | Todd Pendleton | Sale | 11,876 | $54.55 |
| May 15, 2026 | Shriram Revankar | Sale | 3,000 | $54.90 |
| May 12, 2026 | Robert J Park | Sale | 4,504 | $56.62 |
| May 12, 2026 | Robert J Park | Sale | 391 | $57.35 |
| May 5, 2026 | John D Couling | Sale | 6,928 | $57.47 |
DLB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Sep 26, 2025 | $1.35B | $255.02M | 2.62 | $472.20M |
| Sep 27, 2024 | $1.27B | $261.82M | 2.69 | $327.25M |
| Sep 29, 2023 | $1.30B | $200.66M | 2.05 | $367.08M |
| Sep 30, 2022 | $1.25B | $184.09M | 1.81 | $318.58M |
| Sep 24, 2021 | $1.28B | $310.23M | 2.97 | $447.75M |
Latest balance sheet: total assets $3.16B, total liabilities $563.89M, cash $669.39M (as of Jun 26, 2026).
DLB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $51.78 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $64.14 |
| Jan 29, 2026 | 8-K Item 2.02 (results) | $63.03 |
| Nov 18, 2025 | 8-K Item 2.02 (results) | $64.96 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $75.34 |
| May 1, 2025 | 8-K Item 2.02 (results) | $76.18 |
| Jan 29, 2025 | 8-K Item 2.02 (results) | $80.63 |
| Nov 19, 2024 | 8-K Item 2.02 (results) | $70.91 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 1, 2024 | 8-K Item 2.02 (results) | — |
| Nov 16, 2023 | 8-K Item 2.02 (results) | — |
More on DLB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.